(Q40206086)

English

New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Yi Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Yukari Takao

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Mamoru Harada

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Shigeru Yutani

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Tatsuya Ide

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Michio Sata

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Kyogo Itoh

7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Akira Yamada

8

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

857-865

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Cytotoxic T cells and viral hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Electroporation in ‘intracellular’ buffer increases cell survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Cellular immune responses against hepatitis C virus: the evidence base 2002

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Clinical significance of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2006.TB03861.X

21 January 2018

Identifiers

10.1111/J.1348-0421.2006.TB03861.X

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40206086&oldid=1888716227"